GHK-Cu + KPV + MOTS-c
Also known as: GHK-Cu/KPV/MOTS-C, Copper peptide + KPV + MOTS-c blend
Pre-mixed three-peptide blend combining GHK-Cu, KPV, and MOTS-c. GHK-Cu is the copper-binding tripeptide glycyl-L-histidyl-L-lysine, studied for collagen synthesis, wound healing, and antioxidant signaling. KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-MSH and acts as an anti-inflammatory via NF-kB inhibition without melanocortin-receptor activation. MOTS-c is a 16-residue mitochondrial-derived peptide that activates AMPK and is studied for metabolic and exercise-mimetic effects. None of the three is FDA-approved as an injectable therapeutic, and there is no controlled human efficacy or safety data for this specific combination — the rationale is inferred from the individual research compounds.
Common research uses
Pricing for GHK-Cu + KPV + MOTS-c
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
No sellers for GHK-Cu + KPV + MOTS-c are indexed yet — we add vendors and their prices as we find them.
COAs for GHK-Cu + KPV + MOTS-c
1 third-party test across 1 vendor. Each card links to the full report.
Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.